Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Revenues $ 14,457,000 $ 15,087,000 $ 47,598,000 $ 50,085,000
Cost of sales 10,067,000 10,368,000 33,229,000 37,310,000
Gross profit 4,390,000 4,719,000 14,369,000 12,775,000
Operating expenses:        
Selling and administrative 5,311,000 4,724,000 14,629,000 13,510,000
Research and development 1,286,000 1,182,000 4,021,000 3,567,000
Total operating expenses 6,597,000 5,906,000 18,650,000 17,077,000
Operating loss (2,207,000) (1,187,000) (4,281,000) (4,302,000)
Other income 8,000
Interest income (expense), net (433,000) (258,000) (1,285,000) (971,000)
Net loss $ (2,640,000) $ (1,445,000) $ (5,566,000) $ (5,265,000)
Net loss per share - basic $ (0.16) $ (0.09) $ (0.34) $ (0.33)
Net loss per share - diluted $ (0.16) $ (0.09) $ (0.34) $ (0.33)
Weighted average number of common shares outstanding - basic 16,538,998 16,048,054 16,510,046 16,021,653
Weighted average number of common shares outstanding - diluted 16,538,998 16,048,054 16,510,046 16,021,653